ArticlePediatric research2026
Sociodemographic and visit differences in screening for household tobacco smoke exposure in pediatric primary care.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPediatric screening for household tobacco smoke exposure (TSE) may help to increase parental access to tobacco treatment and reduce childhood TSE, yet levels remain low. This study aimed to characterize sociodemographic and visit-related factors associated with TSE screening in pediatric primary care.
methodsSecondary analysis of electronic health records for all clinic visits (patients 0-18 years) in a metropolitan health system. Modified Poisson regressions examined the association between patient and visit characteristics and TSE screening.
resultsTSE screening was documented in 84% of all visits (n = 62,161 patients). TSE screening was more likely among patients who were 3 years or older (3-6 years PR 1.40, 95% CI 1.37, 1.42; 7-12 years PR 1.40, 95% CI 1.38, 1.43; 13+ years PR 1.49, 95% CI 1.47, 1.52), patients with insurance (PR 1.05, 95% CI 1.03, 1.08), and those with a diagnosis of reactive airways disease, bronchiolitis, or wheeze (PR 1.07, 95% CI 1.06, 1.08) or preterm birth (PR 1.04, 95% CI 1.03, 1.06).
conclusionPediatric patients with high-risk medical diagnoses were more likely to receive recommended household TSE screening. There are opportunities within pediatric primary care to increase screening for household TSE among younger and underinsured pediatric populations. IMPACT: Pediatric patients with high-risk medical diagnoses were more likely to receive recommended household TSE screening. Levels of household TSE screening were lowest among patients age 2 years and under and those who are underinsured. Increasing systematic screening for household TSE is essential to connect parents who smoke with resources to quit.
Identifiers
41792338What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.